News

FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.

Here’s a look at what payers and providers can expect to occur, why each change is occurring, and how payers and providers can prepare for each change.

FDA's Center for Drug Evaluation and Research approved fewer new treatments in 2019.

Top thought leaders share their favorite non-business reads.

Managed Healthcare Executive surveyed hundreds of healthcare leaders and professionals to collect information on how their organizations are affected by technology. This year’s survey displays data focusing on healthcare organizations’ current status, patient access, data collection, communication, and future with technology.

Healthcare professionals share the investments’ health organizations are making and why.

More consumers are purchasing short-term limited duration insurance plans-which will likely have long-lasting effects to consumers and the insurance market as a whole.

Employer-sponsored insurance keeps many working.

How cancer patients can better organize around their cancer care plans in a more redesigned system.

A new study on a controversial drug shows the scientists who first found a conection with heart attacks and death were possibly right.

The top technologies for 2020 aren’t new, but they are on the cusp of moving into broader use in healthcare.

Ranks have swelled between 2010 and 2017 partly because of access to online learning.

The first FDA-approved product for NASH on the horizon.

Global market for peanut allergy treatments estimate at $4.5 billion.

A new class of drugs for high cholesterol and a novel peanut allergy treatment lead expected approvals.

How pharmacies should adopt value- and performance-based payment models and offer DIR fee reductions for pharmacists’ and their patients’ benefit.

A new class of drugs for high cholesterol and a novel peanut allergy treatment lead expected approvals.

Although commenting on the Proposed Rule is closed, if finalized, the Proposed Rule would have a significant impact on the way hospitals and physicians structure future compensation arrangements.

In first year of operation, CareMount ACO physicians reduced costs while improving care.

New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.

Patients' use of referrals has declined by 44% in the past year, and they now use an average of three different online sources to find a doctor, according to Doctor.com's annual consumer survey report. 

Script.AI, healthcare IT solution, is bringing transparency to the prescription drug market and finding 46% savings opportunities for payers.

Cleveland Clinic and GYANT partner to digitally transform the post-discharge process through engagement which helps patients stay in touch with their providers and offering a more efficient patient and caregiver experience.

Novel cancer drug snags FDA approval.

Traditional party drug known as ecstasy is undergoing clinical trials to assist in PTSD treatment.

Some of the biggest trends this year that will affect the healthcare workforce.

Crowding of the emergency department can often affect health outcomes for patients and even contribute to patient readmissions, creating a vicious cycle for an already troubling crowding problem. 

Michael J. McGuinness and Aarthi Belani share how convergence transactions pose challenges such as distinct regulatory regimes, potentially incompatible corporate cultures, and differing expectations for executive compensation, while working out these alliances.

Of the $350 billion widely cited as the cost of administrative complexity, $40.6 billion is spent on eight business transactions.